Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
5.00
+0.50 (11.11%)
At close: Aug 13, 2025, 4:00 PM
4.810
-0.190 (-3.79%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
Corvus Pharmaceuticals Employees
Corvus Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 3 or 10.71% compared to the previous year.
Employees
31
Change (1Y)
3
Growth (1Y)
10.71%
Revenue / Employee
n/a
Profits / Employee
-$1,455,968
Market Cap
372.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRVS News
- 1 day ago - Corvus Pharmaceuticals: Positive Phase 1 Soquelitiinb Trial Data Brings 2025 Catalysts - Seeking Alpha
- 5 days ago - Corvus Pharmaceuticals, Inc. (CRVS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis - GlobeNewsWire
- 2 months ago - Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Why Is Corvus Pharmaceuticals Stock Soaring On Friday? - Benzinga
- 3 months ago - Corvus Pharmaceuticals, Inc. (CRVS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire